Humankind Investments’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,868
Closed -$319K 113
2025
Q3
$319K Buy
3,868
+317
+9% +$24.9K 0.07% 106
2025
Q2
$286K Sell
3,551
-146
-4% -$11.3K 0.07% 114
2025
Q1
$297K Buy
3,697
+122
+3% +$10.1K 0.08% 113
2024
Q4
$293K Sell
3,575
-328
-8% -$27.3K 0.07% 118
2024
Q3
$322K Buy
3,903
+270
+7% +$20.2K 0.12% 106
2024
Q2
$255K Sell
3,633
-5,610
-61% -$401K 0.07% 119
2024
Q1
$685K Sell
9,243
-181
-2% -$12.6K 0.18% 63
2023
Q4
$623K Sell
9,424
-101
-1% -$6.32K 0.18% 64
2023
Q3
$599K Sell
9,525
-2,071
-18% -$129K 0.25% 52
2023
Q2
$656K Buy
+11,596
New +$643K 0.26% 53

Other funds holding MET

Humankind Investments's MET Position: Q4 2025 in Review

Humankind Investments sold out of MetLife (MET) in Q4 2025, closing a stake of 3,868 shares — an estimated $319K sold.

Humankind Investments first reported a position in MET in Q2 2023 and held it in 10 quarters. The position peaked at $685K in Q1 2024. 1,439 funds tracked by Wall St. Rank hold MET as of Q4 2025.

  • Humankind Investments reported no remaining MetLife position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 3,868 MetLife shares in Q4 2025, an estimated $319K.
  • Humankind Investments first reported a position in MetLife in Q2 2023 and held it in 10 quarters.
  • Humankind Investments's MetLife position peaked at $685K in Q1 2024.
  • 1,439 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.